Shares of The Clorox Company (NYSE:CLX – Get Free Report) have received an average rating of “Reduce” from the fifteen brokerages that are currently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $158.21.
Several brokerages recently commented on CLX. Evercore ISI lifted their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Barclays upped their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th.
Check Out Our Latest Stock Analysis on CLX
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm earned $2.16 earnings per share. On average, sell-side analysts forecast that Clorox will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.16%. Clorox’s payout ratio is 133.33%.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the company. Brooklyn Investment Group lifted its position in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new stake in Clorox during the 4th quarter valued at approximately $26,000. Prospera Private Wealth LLC purchased a new position in Clorox in the 3rd quarter worth approximately $27,000. Continuum Advisory LLC boosted its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Finally, Millstone Evans Group LLC purchased a new stake in Clorox during the 4th quarter valued at approximately $31,000. Institutional investors own 78.53% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How to Most Effectively Use the MarketBeat Earnings Screener
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- 5 discounted opportunities for dividend growth investors
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.